• Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

SHP:LN

4,923.000 GBp 36.000 0.74%

As of 11:35:27 ET on 08/29/2014.

Snapshot for Shire PLC (SHP)

Open: 4,897.000 Day's Range: 4,897.000 - 4,923.000 Volume: 1,349,061
Previous Close: 4,887.000 52wk Range: 2,371.000 - 5,045.000 1-Yr Rtn: +107.91%

Stock Chart for SHP

No chart data available.
  • SHP:LN 4,923.000
  • 1D
  • 1M
  • 1Y
4,887.000
Interactive SHP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SHP

Current P/E Ratio (ttm) 28.9656
Estimated P/E(12/2014) 25.0669
Relative P/E vs. UKX 1.6837
Earnings Per Share (USD) (ttm) 2.8210
Est. EPS (USD) (12/2014) 3.2570
Est. PEG Ratio 2.0204
Market Cap (M GBP) 29,024.16
Shares Outstanding (M) 589.56
30 Day Average Volume 3,271,364
Price/Book (mrq) 7.9895
Price/Sale (ttm) 8.6321
Dividend Indicated Gross Yield 0.25%
Cash Dividend (GBp) 2.2400
Dividend Ex-Date 09/03/2014
5 Year Dividend Growth 13.16%
Next Earnings Announcement 10/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SHP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SHP

Shire PLC markets, licenses and develops prescription medicines. The Group focuses its operations on attention deficit and hyperactivity disorders, human genetic therapies, gastrointestinal, and renal diseases.

Flemming OrnskovChief Executive OfficerJames BowlingInterim CFO/Senior VP/Controller
Tatjana MaySecretary/General CounselJeff PoultonHead:Investor Relations
More Company Profile & Key Executives for SHP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil